Complete video at: http://fora.tv/2009/05/19/A_Closer_Look_at_Personal_Genomic_Testing A panel of DNA policy and research experts connect the openness affiliated with the web 2.0 phenomenon to the growing acceptance for personal genetic testing. "We have a different sensitivity to privacy because there are stigmas in previous generations that we just don't have anymore," says 23andMe co-founder Linda Avey. ----- Personal genomic testing (the analysis of the DNA of individuals) is now available for less than $400. The consequences of personal genetic testing are often debated, with advocates arguing that genetic data can lead to improved health care and critics warning that consumers may be unduly worried upon learning results. California regulations impose conditions on firms providing personal genomic testing. This symposium examines genomic testing technology, its ramifications, government regulation of the industry, and whether individuals should have their genome analyzed. - Commonwealth Club of California Linda Avey has over 20 years of sales and business development experience in the biopharmaceutical industry in San Francisco, Boston, San Diego, and Washington, D.C. Prior to starting 23andMe, she developed translational research collaborations with academic and pharmaceutical partners for Affymetrix and Perlegen Sciences. Daniel Ballon is Senior Policy Fellow in Technology Studies at the Pacific Research Institute. Dr. Ballon's research focuses on policies which promote innovation in the technology sector. He previously spent ten years conducting applied research in biotechnology, and his work has been published in leading biomedical journals. David C. Magnus, Ph.D. is Associate Professor of Pediatrics and Medicine, Stanford University. Magnus is also Director of the Stanford Center for Biomedical Ethics.
Questions about Privacy vs Convenience in Personal Genetic Tech
Want more info about Privacy vs Convenience in Personal Genetic Tech?
Get free advice from education experts and Noodle community members.